XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
UNAUDITED CONSOLIDATED STATEMENTS OF NET INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Net revenue $ 155,675 $ 148,509
Operating cost:    
Salaries and related costs 93,731 86,040
Rent, supplies, contract labor and other 31,916 30,100
Provision for credit losses 1,627 1,512
Total operating cost 127,274 117,652
Gross profit 28,401 30,857
Corporate office costs 14,085 13,859
Operating income 14,316 16,998
Other income (expense):    
Interest expense, debt and other (1,968) (2,560)
Interest income from investments 1,543 64
Change in fair value of contingent earn-out consideration 612 (698)
Change in revaluation of put-right liability (80) (149)
Equity in earnings of unconsolidated affiliate 271 274
Relief Funds 0 467
Other 62 0
Total other income (expense) 440 (2,602)
Income before taxes 14,756 14,396
Provision for income taxes 3,139 2,969
Net income 11,617 11,427
Less: Net income attributable to non-controlling interest:    
Redeemable non-controlling interest - temporary equity (2,227) (2,720)
Non-controlling interest - permanent equity (1,344) (1,297)
Net income attributable to non-controlling interest (3,571) (4,017)
Net income attributable to USPH shareholders $ 8,046 $ 7,410
Basic earnings per share attributable to USPH shareholders (in dollars per share) $ 0.46 $ 0.58
Diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 0.46 $ 0.58
Shares used in computation - basic (in shares) 15,017 13,025
Shares used in computation - diluted (in shares) 15,017 13,025
Dividends declared per common share (in dollars per share) $ 0.44 $ 0.43
Net Patient Revenue [Member]    
Revenues:    
Net revenue $ 131,075 $ 126,581
Other Revenue [Member]    
Revenues:    
Net revenue $ 24,600 $ 21,928